Abstract:ABSTRACT Although vaginitis is closely related to vaginal microecology in females, the precise composition and functional potential of different types of vaginitis remain unclear. Here, metagenomic sequencing was applied to analyze the vaginal flora in patients with various forms of vaginitis, including cases with a clue cell proportion ranging from 1% to 20% (Clue1_20), bacterial vaginitis (BV), vulvovaginal candidiasis (VVC), and BV combined with VVC (VVC_BV). Our results identified Prevotella as an important biomarker between BV and Clue1_20. Moreover, a gradual decrease was observed in the relative abundance of shikimic acid metabolism associated with bacteria producing indole as well as a decline in the abundance of Gardnerella vaginalis in patients with BV, Clue1_20, and healthy women. Interestingly, the vaginal flora of patients in the VVC_BV group exhibited structural similarities to that of the VVC group, and its potentially functional characteristics resembled those of the BV and VVC groups. Finally, Lactobacillus crispatus was found in high abundance in healthy samples, greatly contributing to the stability of the vaginal environment. For the further study of L. crispatus , we isolated five strains of L. crispatus from healthy samples and evaluated their capacity to inhibit G. vaginalis biofilms and produce lactic acid in vitro to select the potential probiotic candidate for improving vaginitis in future clinical studies. Overall, we successfully identified bacterial biomarkers of different vaginitis and characterized the dynamic shifts in vaginal flora between patients with BV and healthy females. This research advances our understanding and holds great promise in enhancing clinical approaches for the treatment of vaginitis. IMPORTANCE Vaginitis is one of the most common gynecological diseases, mostly caused by infections of pathogens such as Candida albicans and Gardnerella vaginalis . In recent years, it has been found that the stability of the vaginal flora plays an important role in vaginitis. Furthermore, the abundant Lactobacillus -producing rich lactic acid in the vagina provides a healthy acidic environment such as Lactobacillus crispatus . The metabolites of Lactobacillus can inhibit the colonization of pathogens. Here, we collected the vaginal samples of patients with bacterial vaginitis (BV), vulvovaginal candidiasis (VVC), and BV combined with VVC to discover the differences and relationships among the different kinds of vaginitis by metagenomic sequencing. Furthermore, because of the importance of L. crispatus in promoting vaginal health, we isolated multiple strains from vaginal samples of healthy females and chose the most promising strain with potential probiotic benefits to provide clinical implications for treatment strategies.

Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment

The Restoration of the Vaginal Microbiota after Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

Molecular Analysis of the Diversity of Vaginal Microbiota Associated with Bacterial Vaginosis

Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR

Predictive Value of the Composition of the Vaginal Microbiota in Bacterial Vaginosis, a Dynamic Study to Identify Recurrence-Related Flora

16S rRNA Female Reproductive Microbiome Investigation Reveals Dalfopristin, Clorgyline, and Hydrazine as Potential Therapeutics for the Treatment of Bacterial Vaginosis

Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples

Molecular Analysis of the Relationship Between Specific Vaginal Bacteria and Bacterial Vaginosis Metronidazole Therapy Failure

Vaginal Microbiota Transplantation for the Treatment of Bacterial Vaginosis: a Conceptual Analysis

Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.

Vaginal microbiota transplantation for treatment of bacterial vaginosis:a review

Illumina Sequencing 16S Rrna Tagging Reveals Diverse Vaginal Microbiomes Associated with Bacterial Vaginosis

Leveraging 16S Rrna Data to Uncover Vaginal Microbial Signatures in Women with Cervical Cancer

Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis

Characterization of vaginal fungal communities in healthy women and women with bacterial vaginosis (BV); a pilot study

Interpretation of vaginal metagenomic characteristics in different types of vaginitis

Treatment of Bacterial Vaginosis: A Comparison of Metronidazole and Clindamycin on Human Anaerobic Bacteria and Lactobacilli

Characteristics and potential diagnostic ability of vaginal microflora in patients with aerobic vaginitis using 16S Ribosomal RNA sequencing

Diverse Vaginal Microbiomes in Reproductive-Age Women with Vulvovaginal Candidiasis.

[Longitudinal Analysis of Vaginal Microbiota in Women with Recurrent Vulvovaginal Candidiasis].

The Female Vaginal Microbiome in Health and Bacterial Vaginosis